Search Results - Sandhya Sapra
- Showing 1 - 3 results of 3
-
1
-
2
Patient-reported experiences during and following treatment with belantamab mafodotin for relapsed/refractory multiple myeloma in the DREAMM-2 study by Anna Cardellino, Julia R. Correll, Mona Martin, Boris Gorsh, Sandhya Sapra, Rakesh Popat
Published in Frontiers in Oncology (2023-12-01)Get full text
Article -
3
P964: PATIENT (PT)-REPORTED OUTCOMES IN PTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA (RRMM) TREATED WITH BELANTAMAB MAFODOTIN (BELAMAF) VS POMALIDOMIDE/LOW DOSE DEXAMETHASONE (PD)... by Vania Hungria, Katja Weisel, Brooke Currie, Sue Perera, Neal Sule, Wei He, Astrid Mckeown, Sandhya Sapra, Linda Nelsen, Mary LI, Sophie Barale, Julia Boyle, Kaytlyn Mcpoyle, Meletios A. Dimopoulos
Published in HemaSphere (2023-08-01)Get full text
Article
